Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SILTUXIMAB vs SIMVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SILTUXIMAB vs SIMVASTATIN: Safety Overview

Metric SILTUXIMAB SIMVASTATIN
Total FAERS Reports 472 27,079
Deaths Reported 89 2,792
Death Rate 18.9% 10.3%
Hospitalizations 145 8,824
Average Patient Age 47.4 yrs 66.6 yrs
% Female Patients 56.9% 47.5%
FDA Approval Date N/A Apr 14, 2009
Manufacturer Recordati Rare Diseases, Inc. Aphena Pharma Solutions - Tennessee, LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription